Daisuke Ishikawa
发表
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
Y. Hasegawa,
Y. Sekido,
Mitsuo Sato,
2013,
Cancer research.
I. Narita,
K. Nakata,
Daisuke Ishikawa,
2015,
The Journal of Immunology.
Daisuke Ishikawa,
Hiroshi Tanaka,
Kosuke Ichikawa,
2022,
Scientific reports.
T. Mitsudomi,
Y. Sekido,
T. Nakagawa,
2012
.
Y. Sekido,
Mitsuo Sato,
T. Nakagawa,
2013
.
G. Watanabe,
M. Oda,
W. Klepetko,
2014,
Oncology reports.
I. Narita,
K. Nakata,
Daisuke Ishikawa,
2015,
The Journal of Immunology.
K. Nakata,
Daisuke Ishikawa,
Kosuke Ichikawa,
2015
.
Daisuke Ishikawa,
Hiroshi Tanaka,
Kosuke Ichikawa,
2021,
Scientific reports.
K. Nishio,
Daisuke Ishikawa,
T. Sekiya,
2022,
Cancers.
T. Nakagawa,
S. Yano,
Kunio Matsumoto,
2014,
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
T. Nakagawa,
S. Yano,
Kunio Matsumoto,
2013,
International journal of cancer.
T. Nakagawa,
S. Yano,
Kunio Matsumoto,
2013,
PloS one.
T. Mitsudomi,
Y. Sekido,
T. Nakagawa,
2012,
Molecular Cancer Therapeutics.
T. Mitsudomi,
Y. Sekido,
T. Nakagawa,
2012
.
mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF
T. Nakagawa,
S. Yano,
Kunio Matsumoto,
2013,
PloS one.
I. Narita,
Daisuke Ishikawa,
Aya Ohtsubo,
2016,
BMC Cancer.
O. Matsui,
H. Ikeda,
S. Yano,
2013,
JOP : Journal of the pancreas.
K. Ishizawa,
Daisuke Ishikawa,
T. Toubai,
2020,
Case Reports in Oncology.
T. Nakagawa,
S. Yano,
Kunio Matsumoto,
2013,
International journal of cancer.
S. Yano,
K. Yasumoto,
K. Ohtsubo,
2012,
Gan to kagaku ryoho. Cancer & chemotherapy.
I. Narita,
Daisuke Ishikawa,
Aya Ohtsubo,
2016,
BMC Cancer.